Day 3 agenda

Friday, November 24

9.00-10.30

Medical Cannabis Policies and unintended consequences

Plenary session – Main hall, screening to halls 1 and 2

What are the effects and impacts of the wide scale of cannabis-related policies to patients and medical practice. This section will be focused on children, teenagers and medical cannabis

Chair:
  • Nicola Singleton (EMCDDA)
Speakers:
  • Alex Stevens (Kent Uni, ISSDP)
  • Simon Lenton (National Drug Research Institute, Curtin University – TBC)
    + other speakers based on abstracts selection

10.30-11.00             Coffee break

11.00-12.30

Prague Medical Cannabis Declaration 2017

Plenary session – Main hall, screening to halls 1 and 2

Medical Cannabis and Cannabinoids in the 21st century: what the medicine and the global control régime is to do. Public announcement of the objectives and “call to action” for every interested party.

Chair:
  • Steph Sherer (ASA & IMCPC)
Speakers:
  • Richard Rokyta (President of the Czech Medical Academy)
  • Michel Kazatchkine (member of the Global Commission on Drug Policy, and United Nations Secretary-General’s Special Envoy for AIDS in Eastern Europe and Central Asia)
  • Pavel Bém (Global Commission for Drug Policy)
  • Tomáš Zábranský (ResAd, ICCI)
  • Hana Vagnerova (KOPAC, Czech association of cannabis patients)

12.30 – 13.30          Lunch

13.30-15.00

Cannabis in the doctor’s office

Parallel session – main hall

How the medical practitioners shall approach new paradigm in the medicine. Where to get the newest information, how to acquire the best practices, how to talk to patients about the new medicines.

Chair:

Radovan Hřib (Chief Medical Doctor, Centre for Pain Treatment, St. Ann’s Faculty Hospital in Brno)

Speaker:

Eva Dokoupilová (rheumatologist, Chief medical doctor at the Medical Plus, ambulatory services, Uherské Hradiště)


Access research priority mapping

Parallel session – hall 1

There are three verticals in the medical cannabis research – medical biology, natural science, political science. The objective is to examine the empty spaces in all three verticals, find out the relations and specify the priorities where to aim the research first, so the most effective sequence can be maintained.

Chair:
  • Steph Sherer (Americans for Safe Access, and International Medical Cannabis Patients Consortium)
Speakers:
  • Ethan Russo (ICCI, Phytecs, Inc, formerly GW Pharmaceuticals)

+ other discussants based on abstracts selection


Outside the labs

Parallel session – hall 2

How the evidence-based medicine can learn from successful causal treatment cases of natural healers

Chair:
  • Tomáš Zábranský (ResAd, ICCI)
Speakers:
  • Jindřich Bayer, MA (Cure for Cancer: The Rick Simpson Protocol)

+ other discussants based on abstracts selection


15.00 – 15.30          Coffee break

15.30-17.00

Closing ceremony

Main hall, screening to halls 1 and 2

Results and outcomes. The future is bright, if we find the common ground. The movement cannot be stopped.

Chair:
  • Tomáš Zábranský (ResAd, ICCI)
Speakers:
  • Steph Sherer (Americans for Safe Access, and International Medical Cannabis Patients Consortium)
  • Lumír Ondřej Hanus (Hebrew University in Jerusalem, ICCI)